For the month ended 31 May 2026, Metis TechBio Co., Ltd. (METIS TECHBIO-P) reported no changes in either authorised or issued share capital, according to the company’s latest monthly return filed with Hong Kong Exchanges and Clearing Limited on 4 June 2026.

Authorised / Registered Share Capital • Domestic unlisted ordinary shares: 99.59 million shares at RMB 0.10 par value, representing RMB 9.96 million authorised capital. • H-shares: 1.05 billion shares at RMB 0.10 par value, representing RMB 105.29 million authorised capital. Total authorised capital therefore remained at RMB 115.25 million, unchanged from the previous month.

Issued Shares and Treasury Shares • Domestic unlisted ordinary shares outstanding: 99.59 million. • H-shares outstanding: 1.05 billion. • The company held no treasury shares, and there were no share issuances, cancellations or repurchases during the month.

Public Float Confirmation The issuer confirmed that the H-share public float satisfied the HKEX’s minimum threshold of 15 percent of issued shares as at 31 May 2026.

Equity Incentives Under the Pre-IPO Share Option Scheme, 18.39 million options remained outstanding; no options were exercised, cancelled or lapsed in May 2026, and consequently no new H-shares were issued under the scheme.

Other Instruments The company reported no warrants, convertible securities, or other agreements that could dilute the share base.

The filing was signed by Chairman, Executive Director and CEO Tsai-Ta Lai.